Psychomotor Therapy for Very Premature Infants (VPI)

March 31, 2026 updated by: University Hospital, Toulouse

Early Post Hospital Discharge Psychomotor Therapy Intervention Program: Effect on the Development in Very Preterm Infants at 2-years Corrected Age

Our current reflexion is that sensory dys-stimulations, including vestibule-proprioceptive disorders and unbalanced between brain and brainstem maturation of the neonatal period involve an early deviant development for immature infants that will be cascaded through the brain scaffolding and later development. The primary purpose is to determine whether the Early Psychomotor Therapy Intervention Program improves development and behavior in very preterm infants (VPI) at 24-month corrected age (CA).

Study Overview

Status

Completed

Conditions

Detailed Description

VPI < 30 week of amenorrhea were randomized, in a simple blind controlled trial. The psychomotor development was evaluated according to the Bayley Scales of Infant Development-III (BSID-III) at 2 years CA. An intermediate point was provided at 9 months CA. Pediatric standardized assessments and psychologist semi-directive interviews were conducted. Parents also completed a self-administering questionnaire relating to the post-traumatic stress. The intervention consisted on 20 therapy sessions between 2 and 9 months CA, in order to support infants' development, and parent-infant interactions and adjustment.

Extended description of the protocol, including more technical information (as compared to the Brief Summary) if desired. Do not include the entire protocol; do not duplicate information recorded in other data elements, such as eligibility criteria or outcome measures.

Study Type

Interventional

Enrollment (Actual)

162

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Midi-Pyrénées
      • Albi, Midi-Pyrénées, France, 81013
        • CH ALBI
      • Auch, Midi-Pyrénées, France, 32008
        • CH Auch
      • Cahors, Midi-Pyrénées, France, 46005
        • CH Cahors
      • Castres, Midi-Pyrénées, France, 81108
        • Ch Castres
      • Foix, Midi-Pyrénées, France, 09017
        • CHIVA centre hospitalier du val d'Ariège
      • Montauban, Midi-Pyrénées, France, 82013
        • CH Montauban
      • Tarbes, Midi-Pyrénées, France, 65013
        • CH Tarbes
      • Toulouse, Midi-Pyrénées, France, 30159
        • Hopital des Enfants
      • Toulouse, Midi-Pyrénées, France, 31076
        • Clinique Sarrus Teinturiers
      • Toulouse, Midi-Pyrénées, France, 31082
        • Clinique Ambroise Pare

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 years to 2 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Infants with a gestational age between 24 and 30 weeks.

Exclusion Criteria:

  • Infants with congenital disease,
  • Infants with brain bleeding grade III-IV,
  • Infants with periventricular leucomalacia,
  • Infants whose mothers had a documented history of physical or mental illness, or drug abuse
  • Infants from non-French -speaking families.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Psychomotor therapy
Early post hospital discharge psychomotor therapy.
The intervention consisted on 20 psychomotor therapy sessions between 2 and 9 months, in order to support infants' development, and parent-infant interactions and adjustment. The therapy was based on body and emotional positive feelings and experiences, leading to improve sensory motor and perceptive integration, interactive and exploratory behaviors, physiological and tonic-emotional self-regulation, motor organization and early coordination. The intervention was a partnership with the parents, leading to decode the baby needs and expectations, for the parents to experiment more positive feelings, to become more confident in their own skills and more sensitive, and in synchrony with their baby. Intervention was supported by a detailed assessment scale implemented in the regional network related to the follow-up for vulnerable babies.
No Intervention: Control
No specific support.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychomotor development assessment.
Time Frame: Year 2
Assessed by the Bayley Scale Third Edition BSID-III.
Year 2

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The acceptability of the protocol by the parents for the intervention group.
Time Frame: Month 9
Assessed by a self-questionnaire given by the neonatologist at the end of the treatment.
Month 9
The quality of parenting.
Time Frame: Month 9; Year 2
Assessed by a grid (established by the team of child psychiatry neonatology).
Month 9; Year 2
The clinical evolution of the child assessed by a standardized neurological examination.
Time Frame: Months 3, 6, 9, 12, 18, 24
Assessed during the consultations planned in the network (neonatologists of the CHU), based on a standardized neurological examination.
Months 3, 6, 9, 12, 18, 24

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Corinne Alberge, MD, Hôpital des enfants, Toulouse

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2007

Primary Completion (Actual)

December 1, 2013

Study Completion (Actual)

July 8, 2017

Study Registration Dates

First Submitted

March 14, 2017

First Submitted That Met QC Criteria

March 21, 2017

First Posted (Actual)

March 28, 2017

Study Record Updates

Last Update Posted (Actual)

April 6, 2026

Last Update Submitted That Met QC Criteria

March 31, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Premature Infant

Clinical Trials on Early post hospital discharge psychomotor therapy

Subscribe